NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Price Passes Above 200-Day Moving Average - Here's Why

Key Points

• NorthWest Health Prop Real Est Inv Trust's stock price exceeded its 200-day moving average, reaching a high of C$5.08 before closing at C$5.01.
• The company has a market capitalization of C$1.25 billion and is currently trading down 1.4% with a PE ratio of -11.95.
• NorthWest Health provides access to a diversified portfolio of healthcare real estate across countries such as Australasia, Brazil, Germany, and Canada.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - )'s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$4.93 and traded as high as C$5.08. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.01, with a volume of 934,071 shares trading hands.

NorthWest Health Prop Real Est Inv Trust Trading Down 1.4%

The stock has a market capitalization of C$1.25 billion, a PE ratio of -11.95, a price-to-earnings-growth ratio of 0.74 and a beta of 1.44. The firm has a 50-day moving average price of C$4.99 and a 200-day moving average price of C$4.93. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.